Skip to content

Association between delta anion gap/delta bicarbonate and patient outcome in surgical patients admitted to intensive care

Evaluation of the delta anion gap / delta bicarbonate correlation in the outcome in the ICU of patients undergoing major surgeries

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
REBEC
Registry ID
RBR-8xh2j23
Enrollment
Unknown
Registered
2023-08-28
Start date
2012-09-03
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic acidosis

Interventions

Upon admission to the ICU, demographic data, intraoperatively relevant data, SAPS 3 and data from laboratory tests were evaluated: arterial blood gases, lactate, serum sodium, chloride and albumin. Af
V03.175.500

Sponsors

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo - HC- FMUSP
Lead Sponsor
Hospital do servidor Público Estadual de São Paulo - HSPE/IAMSPE
Collaborator
Hospital do Câncer de Barretos
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Surgical patients (age = 18 years) admitted to the ICU consecutively during the study period and at least one of the following criteria: severe cardiorespiratory disease (presence of coronary artery disease, aortic surgery, chronic obstructive pulmonary disease, or stroke); cancer surgery with extensive resection (esophagectomy, total gastrectomy, liver resection, pancreatectomy, cystectomy or total colectomy); surgical time greater than 6 hours; severe polytrauma; Massive intraoperative blood loss (hematocrit < 20%); intraoperative circulatory shock (mean arterial pressure < 60 mmHg) requiring vasopressors; previous nutritional disorder; body mass index < 20; patients over 65 years of age with evidence of physiological limitation in at least one vital organ

Exclusion criteria

Exclusion criteria: Patients who stayed less than 24 hours in the intensive therapy ; patients with low life expectancy (cancer with no prospect of treatment); patients with liver failure - (child B or C); patients with renal insufficiency (creatinine clearance 126 mg/dL after perioperative 8-hour fasting

Design outcomes

Primary

MeasureTime frame
Expected outcome 1: Patients with delta anion gap/delta bicarbonate values ??below 1.0 would have a worse outcome in the ICU with higher associated mortality and greater association with complications;Outcome found 1: Comparing the metabolic acidosis groups regarding complications that occurred in the ICU, the metabolic acidosis group without other disorders showed a greater association with cardiovascular complications (p = 0.001), mortality in the ICU (p = 0.03) and the sum of all complications during the period in the ICU (p = 0.021)

Secondary

MeasureTime frame
Expected outcome 2: Patients related to Delta AG/Delta Bicarbonate less than 1.0 are expected to show a greater association with negative excess base, higher intraoperative consumption of saline solution and higher chlorine values;Outcome found 2: The total amount of 0.9% saline solution received intraoperatively was evaluated according to the deltaAG/deltaBic classification, with a median of 1250 mL (750-2250) in patients with metabolic acidosis only with high AG, 3000 mL (1500- 4500) for patients with associated hyperchloremic acidosis and 2250 mL (2000-3000) for patients with associated metabolic alkalosis. The base difference showed a negative variation in admission to the ICU greater in patients with associated hyperchloremic acidosis in the amount of -7.8 versus -6.3 in patients with metabolic acidosis with high AG without associated disorders and -4.4 in patients with associated metabolic alkalosis. Chlorine had a value of 113.1±4.6 in patients with associated hyperchloremic metabolic acidosis, a value of 106.3±8.1 in patients with associated metabolic alkalosis, and a value of 111.1±7.1 in patients with metabolic acidosis with increased AG without associated disorder

Countries

Brazil

Contacts

Public ContactPedro Menezes

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo - HC- FMUSP

pedroferro89@gmail.com+55(11)2661-7585

Outcome results

None listed

Source: REBEC (via WHO ICTRP)